Limberg-flap: Prospective Data Collection

June 3, 2011 updated by: Cantonal Hospital of St. Gallen

Prospective Evaluation of Feasibility and Results of the Treatment of Pilonidal Sinus by Excision and Covering of the Defect With a Limberg-flap.

The investigators think, that the treatment of pilonidal sinus with excision and covering of the defect with a Limberg-flap is a very good treatment option. The investigators are introducing this treatment for recurrences of this illness in our clinic and want to analyse the feasibility, the results, the complications and the patients opinion after the treatment.

If the results are good, a prospective randomised study is a further option.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

  1. Patients, that come to our clinic with problems caused by a pilonidal sinus are informed about the different treatment options of the illness.

    • If the patient suffers of a recurrence of the illness, a complete excision, followed by a covering of the defect with a Limberg-flap is recommended.
    • If the patient has the first time problems by a pilonidal sinus, we recommend an open limited excision of the fistulas.
    • In cases with acute infected situation, we first conduct a very limited incision/excision and treat them with antibiotics. The treatments mentioned before are in such cases offered 3 to 4 Weeks after the fist little operation.
  2. All Patients, that wish their pilonidal sinus treated with a complete excision followed by a covering of the defect with a Limberg-flap, are asked if they are willing to participate in the observational study.
  3. Patients, who gave their informed consent for the operation and the study are included.
  4. Preoperative data are recorded.
  5. The patients are operated on and intraoperative data (e.g. how big was the flap) are recorded.
  6. After 3 Weeks the patients are checked and complications, happiness and duration of the time off work are recorded.
  7. After a year the patients are contacted by sending them a postal questionnaire, which they send back to us. Additionally the are contacted by phone. Recurrence, other complications and their opinion concerning the treatment and its consequences are recorded.

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • St. Gallen, Switzerland, 9007
        • Department of surgery, Cantonal hospital of St. Gallen
    • St. Gallen
      • Rorschach, St. Gallen, Switzerland, 9400
        • Department of sugery, Cantonal hospital of St. Gallen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Recurrence or persistence of a pilonidal sinus
  • Elective Limberg-flap operation
  • Written informed consent of the patient for the operation and participation of the study

Exclusion Criteria:

  • Doubts of the capability of the patient to understand the study or to decide.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pilonidal Sinus T. With Limberg F.
All patients treated by excision and covering of the defect by a Limberg-flap, who gave their informed consent to participate in the study, as there is only one study group.
Complete excision of the pilonidal sinus and covering of the defect by a Limberg-flap from one buttock
Other Names:
  • Romboid-flap

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recurrence of a Pilonidal Sinus After Operation Using a Limberg-flap Procedure
Time Frame: 1 year
At 1 year all patients were assessed. Patients with a recurrence of a pilonidal sinus were counted. The result is given as number of patients suffering from a recurrence.
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Minor Complications (Wound Complications)
Time Frame: 1 year
All wound complications were assessed; part of them being only very minor dehiscences or slight infections. They were assessed in the outpatients clinic at 3 Weeks and in the follow-up control initiated at 1 year. All patients suffering from a wound complication that occurred in the first year were counted.
1 year
Reoperations Needed for Treatment of Complication
Time Frame: 1year

All patients were seen at the outpatients clinic at 3 weeks. Follow-up control was initiated at 1 year.

All reoperations that were done were assessed and measured.

1year
Patient Overall Satisfaction With Procedure
Time Frame: 1 year
Follow-up was initiated at 1 year. A postal questionnaire was sent to the patients with a VAS assessing overall satisfaction. Possible values were: lowest: 0; highest 10.
1 year
Body Image Score
Time Frame: 1 year
Patients was sent a postal questionnaire at 1 year, assessing body image with the body image questionnaire adapted from Dunker et al. Body image score resulting form 5 questions: worst 5; best 20.
1 year
Cosmetic Score
Time Frame: 1 year
Patients was sent a postal questionnaire at 1 year, assessing cosmesis with the body image questionnaire adapted from Dunker et al. Cosmetic score resulting form 3 questions: worst 3; best 24.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lukas Marti, M D, Department of surgery, Cantonal hospital of St. Gallen
  • Study Chair: Franc H Hetzer, M D, Department of surgery, Cantonal hospital of St. Gallen

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2006

Primary Completion (Actual)

January 1, 2009

Study Completion (Actual)

September 1, 2009

Study Registration Dates

First Submitted

May 1, 2008

First Submitted That Met QC Criteria

May 5, 2008

First Posted (Estimate)

May 6, 2008

Study Record Updates

Last Update Posted (Estimate)

June 29, 2011

Last Update Submitted That Met QC Criteria

June 3, 2011

Last Verified

June 1, 2011

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EKSG 07/050/2B

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe